* 1. Contact Information: (All reported data is confidential and will remain anonymous)

* 2. What is your role at your institution?

* 3. What is your practice setting? (select one)

Section I: Clinical and Policy Issues in Immuno-Oncology (I-O)

* 4. To the best of your ability, please rate your staff’s current knowledge with regards to the following clinical characteristics of immuno-oncology (I-O). (1 = little to no knowledge, 5 = very knowledgeable)

  1 2 3 4 5
I-O mechanisms of action
I-O indications (specific tumor types treated)  
Response assessment to I-O therapy
I-O sequencing considerations (1st line, 2nd line, 3rd line)
Use of I-O biomarkers        

* 5. Does your institution have a specific I-O program and/or workspace in place to diagnose and manage immune-related adverse events?

T